URETHANE-CROSSLINKED POLYMERIC MICROPARTICLES AND PROCESSES OF MANUFACTURING THE SAME
A first process produces poly(glycerol sebacate) urethane (PGSU)-based microparticles. The first process includes forming a first composition including a poly(glycerol sebacate) (PGS) resin and dispersing the first composition in a continuous fluid phase in the presence of an isocyanate crosslinker to produce PGSU-based microparticles. A second process also produces PGSU-based microparticles. The second process includes forming a first composition including a PGS resin, forming a second composition and combining the first composition and the second composition to produce PGSU-based microparticles, where at least one of the first and the second composition includes an isocyanate crosslinker. An extrusion-spheronization process of crosslinking includes extruding an extrudate including a crosslinkable compound into a continuous fluid phase in a spheronization bath and dispersing the extrudate in the continuous fluid phase to crosslink the crosslinkable compound, where at least one of the extrudate and the continuous fluid phase includes a crosslinker.
1 . A process of producing poly(glycerol sebacate) urethane (PGSU)-based microparticles, the process comprising:
forming a first composition comprising a poly(glycerol sebacate) (PGS) resin; and
dispersing the first composition in a continuous fluid phase in the presence of an isocyanate crosslinker to produce the PGSU-based microparticles.
2 . The process of claim 1 , wherein the crosslinker is present only in the first composition prior to the dispersing.
3 . The process of claim 1 , wherein the crosslinker is present only in the continuous fluid phase prior to the dispersing.
4 . The process of claim 1 , wherein the crosslinker is present in both the first composition and the continuous fluid phase prior to the dispersing.
5 . The process of claim 1 , wherein the dispersing occurs in the presence of a catalyst.
6 . The process of claim 5 , wherein the catalyst is present, prior to the dispersing, in a location selected from the group consisting of only in the first composition, only in the continuous fluid phase, and in both the first composition and the continuous fluid phase.
7 . The process of claim 1 , wherein the first composition further comprises an active pharmaceutical ingredient in a form selected from the group consisting of amorphous, semi-crystalline, crystalline, and combinations thereof.
8 . The process of claim 1 , wherein the PGS resin is present at a concentration in the range of about 40 wt % to about 60 wt % in the first composition, and a ratio of a viscosity of the first composition to a viscosity of the continuous fluid phase is in the range of about 10:1 to about 50:1.
9 . The process of claim 1 , wherein the PGSU-based microparticles have an average particle size in the range of about 25 μm to about 100 μm and a span value of less than 2.0.
10 . The process of claim 1 , wherein the process is an emulsification-solvent evaporation process, where the first composition is dispersed as an emulsion in the continuous fluid phase and the continuous fluid phase comprises a continuous phase liquid.
11 . The process of claim 10 , wherein the first composition further comprises a dispersed phase solvent.
12 . The process of claim 11 further comprising removing the dispersed phase solvent after the dispersing.
13 . The process of claim 10 , wherein the dispersing comprises homogenizing the first composition in the continuous fluid phase.
14 . The process of claim 10 , wherein the dispersing comprises flowing the first composition through a membrane having a pore size in the range of about 2 to about 15 μm.
15 . The process of claim 1 , wherein the process is an extrusion-spheronization process, wherein the first composition is an extrudate and the continuous fluid phase is a spheronization bath.
16 . The process of claim 15 further comprising producing the extrudate by co-extruding a second composition and a third composition to meet and intermingle to form the first composition.
17 . The process of claim 16 , wherein the co-extruding comprises co-extruding the second composition from a first barrel and the third composition from a second barrel of a dual-barrel syringe.
18 . The process of claim 16 , wherein the second composition comprises the crosslinker and the third composition comprises a catalyst.
19 . The process of claim 15 , wherein the continuous fluid phase comprises mineral oil and further comprising washing the PGSU-based microparticles to remove the mineral oil.
20 . The process of claim 15 , wherein the extrudate is substantially free of any solvent.
21 . A process of producing poly(glycerol sebacate) urethane (PGSU)-based microparticles, the process comprising:
forming a first composition comprising a poly(glycerol sebacate) (PGS) resin;
forming a second composition;
wherein at least one of the first composition and the second composition comprises an isocyanate crosslinker; and
combining the first composition and the second composition to produce the PGSU-based microparticles.
22 . The process of claim 21 , wherein the process is a phase separation-coacervation process, where the first composition comprises the PGS resin dissolved in a solvent and the second composition comprises a non-solvent.
23 . An extrusion-spheronization process of crosslinking, the extrusion-spheronization process comprising:
extruding an extrudate comprising a crosslinkable compound into a continuous fluid phase in a spheronization bath; and
dispersing the extrudate in the continuous fluid phase in the spheronization bath to crosslink the crosslinkable compound;
wherein at least one of the extrudate and the continuous fluid phase comprises a crosslinker.
24 . The extrusion-spheronization process of claim 23 , wherein the extruding comprises co-extruding a first composition and a second composition different from the first composition to form the extrudate.